Market revenue in 2023 | USD 59.3 million |
Market revenue in 2030 | USD 83.3 million |
Growth rate | 5% (CAGR from 2023 to 2030) |
Largest segment | Coronary stents |
Fastest growing segment | Accessory Devices |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Intravascular Imaging Catheters and Pressure Guidewires, Coronary Stents, PTCA Balloon Catheters, Accessory Devices |
Key market players worldwide | Abbott Laboratories, Medtronic PLC, Boston Scientific Corp, Koninklijke Philips NV, Cardinal Health Inc, Terumo Corp, Teleflex Inc, B. Braun, Biosensors, BIOTRONIK, Asahi Intecc Co Ltd, Cook Medical, Merit Medical Systems Inc, Haemonetics Corp, Vascular Solutions, Zeon Corp, Alvimedica, Meril Life, Medinol |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to interventional cardiology devices market will help companies and investors design strategic landscapes.
Coronary stents was the largest segment with a revenue share of 51.43% in 2023. Horizon Databook has segmented the Sweden interventional cardiology devices market based on intravascular imaging catheters and pressure guidewires, coronary stents, ptca balloon catheters, accessory devices covering the revenue growth of each sub-segment from 2018 to 2030.
Interventional cardiology procedures, compared to open-heart surgeries, are generally less invasive. This results in shorter hospital stays, reduced complications, and faster recovery for patients. Consequently, there has been an increased preference for interventional cardiology treatments among both patients and healthcare providers in Sweden.
This trend has significantly contributed to the growth of the market. In the country, patients have access to the latest intervention technologies, including coronary artery interventions such as stents, as well as carotid artery angiography and stenting.
Sweden follows a valuebased approach when determining the reimbursement status of pharmaceuticals. This approach involves a cost-effectiveness analysis to assess whether the reimbursed price is reasonable from medicinal, humanitarian, and socioeconomic perspectives.
Horizon Databook provides a detailed overview of country-level data and insights on the Sweden interventional cardiology devices market , including forecasts for subscribers. This country databook contains high-level insights into Sweden interventional cardiology devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account